Yahoo
NasdaqCM - Delayed Quote USD

NeuroSense Therapeutics Ltd. (NRSN)

1.9900 -0.1400 (-6.57%)
At close: October 30 at 4:00:00 PM EDT
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Assets
1,028
4,575
3,185
7,710
Total Liabilities Net Minority Interest
2,588
1,992
4,944
2,091
Total Equity Gross Minority Interest
-1,560
2,583
-1,759
5,619
Total Capitalization
-1,560
2,583
-1,759
5,619
Common Stock Equity
-1,560
2,583
-1,759
5,619
Capital Lease Obligations
170
73
142
211
Net Tangible Assets
-1,560
2,583
-1,759
5,619
Working Capital
-1,738
2,410
-543
5,655
Invested Capital
-1,560
2,583
-1,759
5,619
Tangible Book Value
-1,560
2,583
-1,759
5,619
Total Debt
170
73
142
211
Share Issued
1,627.8580
1,161.4470
768.9520
589.0980
Ordinary Shares Number
1,627.8580
1,161.4470
768.9520
589.0980
12/31/2022 - 12/9/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: